Skip to main content
Loading
Jeff Raphael

Jeff Raphael

Managing Partner, Life Sciences Strategic Advisory, OmniScope Partners
Jeff Raphael is the Managing Partner of OmniScope Partners, an independent boutique investment banking firm dedicated to empowering emerging leaders of the innovation economy to achieve their strategic and financial objectives with bespoke solutions across a range of situations. Jeff’s work as a strategic advisor is differentiated by deep focus and expertise in the life sciences and innovative healthcare sectors, having advised on over 50 closed transactions amounting to $15Bn+ in transaction value. Jeff founded OmniScope Partners with the aim of leveraging the combination of his experiences as an operator and seasoned Wall Street professional to help guide next-generation businesses through key inflection points as they seek to advance life-saving technologies and return value to their investors. Prior to founding OmniScope Partners, Jeff was a Managing Director at Evercore where he was part of the Corporate Advisory practice and the senior leadership team in the firm’s Menlo Park office. Prior to joining Evercore, Jeff held senior roles at Piper Sandler and Jefferies where he led transaction execution in healthcare, specifically focusing on innovation leaders across the biopharma, life sciences and heath tech sectors. Prior to this, Jeff was with DaVita Healthcare Partners leading finance and growth initiatives for operations in Washington D.C., Maryland and northern Virginia. In this capacity, Jeff also supported the company’s Corporate Development team in evaluating potential acquisition targets and developing growth strategies at the local level. Jeff began his career in New York as an investment banking analyst at Credit Suisse. Jeff holds a B.A. from the University of Maryland with concentrations in economics and sociology.
Sessions
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP